General Dermatology

Patients in 8 case studies saw notable improvements in post-traumatic, post-operative, and burn-related scars.

The study is set to begin enrollment later this year.

The ILDS has named 6 young dermatologists from around the world as recipients of the 2025 Young Dermatologists International Achievement Awards for their contributions to dermatology.

You're allowed to be proud of yourself, no matter how long you have been in practice, writes our Fall Editor in Chief Raj Chovatiya, MD, PhD.

At the 2024 SDPA Fall Conference, Audrey Rutherford, MD, discussed the critical role of vulvar biopsies in identifying cancer and other conditions to improve patient outcomes for underdiagnosed vulvar conditions.

Zirwas spoke with Dermatology Times to share the top clinical pearls and key takeaways from his discussion on contact dermatitis.

The target action date for the FDA decision is April 18, 2025.

November is Hyperhidrosis Awareness Month - test your knowledge on the subject.

The study calls for improved diversity in clinical training materials to help future clinicians better recognize conditions on darker skin.

Join Dermatology Times in celebrating National Healthy Skin Month.

November is Hyperhidrosis Awareness Month - test your knowledge on the subject.

With the Affordable Care Act's uncertain future, many Americans are curious about Robert F. Kennedy Jr.'s potential role in the new administration.

Murase noted small molecule treatments, like JAK inhibitors, remain unsafe for pregnant women.

In a session at Elevate-Derm West, Cheever presented on the utilization of AI within dermatology to optimize patient communication and diversify research.

Learn more about the in-depth topics covered in the October 2024 print issue of Dermatology Times.

Motivators like health benefits, altruism, and trust in clinicians enhance participant retention and adherence in melanoma research, according to MEL-SELF findings.

Dermatology Times is looking back on the top stories in dermatology from the month of October.

Dermatology Times is recapping our top expert interviews from the month of October.

A pilot study monitored the disease management, technical challenges, and overall benefits for chronic spontaneous urticaria.

Personalized treatment strategies for infectious skin diseases are being developed using AI algorithms that analyze individual patient data.

A study of the new cleanser included diverse participants, ensuring it is suitable for various skin types and sensitivities.

Del Rosso reviews available and upcoming monoclonal antibodies, including nemolizumab, lebrikizumab, bimekizumab, and more.

The late-breaking data will be presented at ACAAI’s annual Scientific Meeting.

The application of a clinically validated moisturizer before mask-wearing was shown to significantly improve skin barrier function and reduce irritation.

Click here to answer today’s poll and read more about the perception of telehealth treatment in dermatology.

Researchers behind a recent study found that patients with liver disease had a significantly higher prevalence of chronic pruritus.

The multicenter trial reported high response rates and low risk of discontinuation for treating long-term chronic inducible urticaria.

Developed by a panel of global dermatology experts, the SQS addresses the multifaceted nature of skin quality.

Although further research is still needed, dermatologists and patients are generally satisfied with teledermatology treatment.

The app demonstrated high sensitivity (92.0%) and specificity (95.5%) in identifying skin changes through a controlled testing environment.